At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 10:11 ET
Patrick Plewman, an officer of Quest Diagnostics, filed a Form 144 notice to sell 11,717 shares of common stock with an approximate market value of $3.0M. The shares were acquired through restricted stock vesting and a stock option exercise. This is an advance notice of intent to sell, not a completed transaction.
- Reporting owner: Patrick Plewman (Officer)
- Shares to be sold: 11,717 shares of common stock
- Approximate value: $3,015,252.78
- Shares acquired via restricted stock vesting (650 shares on 02/24/2025) and stock option exercise (11,067 shares on 11/09/2026)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access